Pascal joined the RiverVest team as Senior Associate in 2021. In this role, she focuses on sourcing and completing due diligence on prospective portfolio companies, in both the therapeutics and medical devices sectors. She also supports the operational activities of RiverVest’s portfolio companies.

Prior to joining the team, Pascal spent nearly 4 years as an Investment Associate at Kairos Ventures, where she focused on life science investments spanning both therapeutics and medical devices. She was responsible for sourcing potential investment opportunities and completing due diligence. In addition, Pascal served on the Board of Directors of several Kairos Ventures portfolio companies.

Pascal earned a Ph.D. in Molecular Biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes and worked to create compounds that inhibited these structures. Prior to graduate school, Pascal worked as Junior Specialist at the Development Biology Center at the University of California, Irvine, studying mosquito olfaction as a strategy for vector control. She earned a B.S. in Developmental and Cell Biology with a Minor in Business Management from UC Irvine.